2-methyl-N-(4-morpholin-4-ylphenyl)-4-oxo-4H-pyrimido[2,1-b][1,3]benzothiazole-3-sulfonamide structure
|
Common Name | 2-methyl-N-(4-morpholin-4-ylphenyl)-4-oxo-4H-pyrimido[2,1-b][1,3]benzothiazole-3-sulfonamide | ||
|---|---|---|---|---|
| CAS Number | 1031606-15-1 | Molecular Weight | 456.5 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H20N4O4S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 2-methyl-N-(4-morpholin-4-ylphenyl)-4-oxo-4H-pyrimido[2,1-b][1,3]benzothiazole-3-sulfonamide |
|---|
| Molecular Formula | C21H20N4O4S2 |
|---|---|
| Molecular Weight | 456.5 |
| InChIKey | RDXXCEHDPJKFAF-UHFFFAOYSA-N |
| SMILES | Cc1nc2sc3ccccc3n2c(=O)c1S(=O)(=O)Nc1ccc(N2CCOCC2)cc1 |
|
Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: HCMV UL50
External Id: HMS1262
|
|
Name: High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS1303
|